Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study.
Matias IglickiCatharina BuschPaolo LanzettaValentina SaraoDaniele VerittiNicolò RassuMarco LupidiZafer CebeciSamantha Fraser-BellCarolina Bernal-MoralesAnna Sala-PuigdollersJavier Zarranz-VenturaRoberto Gallego-PinazoAniruddha MaitiGiuseppe D'Amico RicciPatricia UdaondoAnat LoewensteinJay ChhablaniDinah ZurPublished in: Eye (London, England) (2022)
We demonstrated similar anatomical and functional efficacy of DEX implant in non-vitrectomized and vitrectomized eyes. Its efficacy was not influenced by full vitrectomy for diabetic retinopathy complications. Safety profile was well balanced between groups.